A Deal for Coronavirus Fiscal Relief
A Deal for Coronavirus Fiscal Relief Alex Brill and Betsey Stevenson | The Hill We recently had the honor of testifying before the House Ways and Means Committee on the effects of inaction on coronavirus fiscal legislation. One of us was invited by the Republicans and...
Brand-name Drugmaker Tactic ‘Product Hopping’ Costs US Healthcare System $4.7 Billion Annually, Study Says
Brand-name Drugmaker Tactic ‘Product Hopping’ Costs US Healthcare System $4.7 Billion Annually, Study Says Maia Anderson | Becker’s Hospital Review “An anti-competitive tactic used by brand-name drugmakers called product hopping costs the U.S....
New Report Shows Brand Drug Product Hopping Costs Billions for Patients and Healthcare System Each Year
New Report Shows Brand Drug Product Hopping Costs Billions for Patients and Healthcare System Each Year Alex Brill | Washington, DC Today, Matrix Global Advisors (MGA) released a new report, “The Cost of Brand Drug Product Hopping,” commissioned by the Coalition for...
Families Need More Pandemic Tax Relief, Democrats Say
Families Need More Pandemic Tax Relief, Democrats Say Stephen Cooper | Law360 “But Alex Brill of the right-leaning American Enterprise Institute said Congress shouldn’t approve more costly economic recovery payments because they aren’t well targeted...- Don’t Let Pandemic Fatigue Inhibit Pandemic Preparedness
- Macroeconomics of the Child Tax Credit
- 2022 Midterms: How a Democratic or GOP Congress May Impact Your Federal Taxes
- ‘The Price of Business’: Discussing State Taxation of Student Loan Forgiveness
- More Concerns with the Massachusetts Millionaire’s Tax
- Revisiting the Tax Treatment of Pass-Through Businesses: A Panel Discussion
- President Biden’s Student Loan Forgiveness: The Impact on Individuals’ State Taxes
- President Biden’s Student Loan Forgiveness: The Impact on State Tax Revenues
- Q&A: Maura Keefe and Alex Brill Discuss Understanding Drug Rebates and Their Role in Promoting Competition
- New PCMA Podcast Highlights Importance of Prescription Drug Rebates
